Letters, Testimony & Comments

March 27, 2003
J. Leighton Read, M.D. General Partner, Alloy Ventures Palo Alto, CA Testifying On Behalf Of The Biotechnology Industry Organization Before The House Energy And Commerce Subcommittee On Health And The House Select Committee On Homeland...
February 14, 2003
The Honorable Mark B. McClellan Commissioner United States Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, Maryland 20852 Re: Personal Importation of Biological Products Dear Dr. McClellan: The Biotechnology Industry...
February 14, 2003
Identifying countries of concern as per the Trade Act of 1974
January 29, 2003
Letter to The Honorable Robert Zoellick, US Trade Representative
January 17, 2003
When I read the agenda for today and saw the emphasis on corporate strategy, it reminded me of a quote by financier Victor Palmieri, who said: "Strategies are okayed in boardrooms that even a child would say are bound to fail. "The...
January 16, 2003
Thank you Dave. Dave Holveck is a good friend, and a forceful champion of our industry. I don't use the word "champion" lightly but few individuals in our industry - in any industry - have gotten back up off the mat after his company took a big...
December 2, 2002
For Pharmaceutical Manufacturers
November 27, 2002
Letter to The Honorable Robert Zoellick, US Trade Representative
November 18, 2002
The Honorable Tom Daschle 509 Hart Senate Office Building Washington DC 20510 Dear Senator Daschle: The Senate will very soon be asked to approve legislation creating a new Department of Homeland Security. However, as the Senate moves toward...
November 16, 2002
November 14, 2002
On October 17, 2002, Judge Henry H. Kennedy of the U.S. District Court for District of Columbia struck down FDA's "pediatric rule." Among other things, the rule allowed FDA to require that drug and biologics applications "...
November 6, 2002
Carl B. Feldbaum, BIO President Since its inception in the 1970's, the biotechnology industry's mission has been to improve and save human lives. The industry has followed through on that commitment with more than 120 new drugs and...
October 24, 2002
The Honorable Mitchell E. Daniels, Jr. Director, Office of Management and Budget Dwight D. Eisenhower Executive Office Building, #252 17th Street and Pennsylvania Avenue, N.W. Washington, D.C. 20503 Dear Director Daniels: We are writing to...
October 4, 2002
Dear Governor Kitzhaber: This letter explains why FDA objects to the pending ballot initiative to require the mandatory labeling of foods and food additives produced using genetic engineering sold in Oregon, or produced in Oregon and shipped to...
October 4, 2002
Sent to Governor Kitzhaber (October 4, 2002).
October 2, 2002
Dear Senator Daschle: The Biotechnology Industry Organization (BIO) strongly supports the Conference Agreement on the Department of Justice Authorization Act (HR 2215) and urges passage by the U.S. Senate. The House of Representatives passed the...
September 20, 2002
Letter from BIO to the U.S. House of Representatives strongly urging members not to sign the discharge petition (H. Res. 517) offered by the Democratic leadership that would bring the "Greater Access to Affordable Pharmaceuticals Act of 2001...